Skip to main content

Vitamin D Deficiency

9
Pipeline Programs
15
Companies
10
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
5
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

10 companies ranked by most advanced pipeline stage

Sandoz
SandozAustria - Kundl
1 program
1
AliskirenPhase 4
MSD
MSDIreland - Ballydine
3 programs
1
2
cholecalciferolPhase 31 trial
cholecalciferolPhase 31 trial
MK0822APhase 21 trial
Active Trials
NCT00242476Completed216Est. Jul 2006
NCT01465178Completed62Est. Dec 2014
NCT00681590Completed105Est. Apr 2009
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
3 programs
1
2
cholecalciferolPhase 3
cholecalciferolPhase 3
MK0822APhase 2
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
1
cholecalciferolPhase 31 trial
Active Trials
NCT00292591Completed501Est. Jan 2010
Pfizer
PfizerNEW YORK, NY
2 programs
1
cholecalciferolPhase 11 trial
cholecalciferolN/A1 trial
Active Trials
NCT01508845Completed61Est. Jun 2013
NCT01268176Completed62Est. Jun 2012
Merck & Co.
Merck & Co.RAHWAY, NJ
2 programs
MK0822APHASE_2
cholecalciferolPHASE_3
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Redoxon VIN/A1 trial
Active Trials
NCT02876315Completed42Est. Dec 2019
Abiogen
AbiogenItaly - Pisa
1 program
Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation N/A1 trial
Active Trials
NCT06452082Completed200Est. Sep 2025
Martin Pharmaceuticals
1 program
cholecalciferolN/A1 trial
Active Trials
NCT01503216Completed120Est. May 2012
Faes Farma
Faes FarmaSpain - Leioa
1 program
Calcifediol 75mcgPHASE_2_31 trial
Active Trials
NCT04735926Completed674Est. Apr 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MSDcholecalciferol
MSDcholecalciferol
Human BioSciencescholecalciferol
Faes FarmaCalcifediol 75mcg
MSDMK0822A
Pfizercholecalciferol
AbiogenRisk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation
Oregon TherapeuticsRedoxon VI
Martin Pharmaceuticalscholecalciferol
Pfizercholecalciferol

Clinical Trials (10)

Total enrollment: 2,043 patients across 10 trials

NCT01465178MSDcholecalciferol

Improving the Understanding of the Response to Vitamin D Supplementation

Start: Dec 2011Est. completion: Dec 201462 patients
Phase 3Completed
NCT00681590MSDcholecalciferol

Safety of Vitamin D Supplementation in Older Persons

Start: Apr 2008Est. completion: Apr 2009105 patients
Phase 3Completed

Evaluation of Vitamin D Requirements During Pregnancy

Start: Jan 2004Est. completion: Jan 2010501 patients
Phase 3Completed
NCT04735926Faes FarmaCalcifediol 75mcg

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency

Start: Dec 2020Est. completion: Apr 2023674 patients
Phase 2/3Completed

A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)

Start: Sep 2005Est. completion: Jul 2006216 patients
Phase 2Completed
NCT01268176Pfizercholecalciferol

The Effect of a Meal on Vitamin D Absorption

Start: Dec 2010Est. completion: Jun 201262 patients
Phase 1Completed
NCT06452082AbiogenRisk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation

Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl

Start: Mar 2024Est. completion: Sep 2025200 patients
N/ACompleted

The Effect of Combinatorial Nutritional Supplementation on Immune Function in Healthy Older Adults

Start: Dec 2016Est. completion: Dec 201942 patients
N/ACompleted

Safety and Bioefficacy of Vitamin D2 and Vitamin D3

Start: Jan 2012Est. completion: May 2012120 patients
N/ACompleted
NCT01508845Pfizercholecalciferol

A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption

Start: Jan 2012Est. completion: Jun 201361 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 late-stage (Phase 3) programs, potential near-term approvals
15 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.